Yining Zhao

Dr. Yining Zhao is currently President and Chief Operating Officer at Ansun Biopharma. He is also Chairman and co-founder of Transcenta Holding. He was Venture Partner at Lilly Asia Ventures during 2015-2018. Prior to his entrepreneurial career, Dr. Zhao worked in the areas of Strategy Management and Business Development at multinational biopharmaceutical companies for more than 20 years. He was Executive Strategy Director at Global Commercial Operations at Amgen in Thousand Oaks, California. Before that he was the Asia Strategy Lead at Pfizer in Boston.

Dr. Zhao received his B.S. in Pharmaceutical Sciences from Fudan University, Ph.D. in Analytical Chemistry from Ghent University, and MBA from MIT. He has been a member of the executive board of the MIT Sloan School of Management since 2017.